Literature DB >> 16250688

Behavioral medicine and the management of HIV/AIDS.

N Schneiderman1.   

Abstract

Psychosocial treatment studies provide a method for conducting causal investigations within a clinical environment. They can also inform about relations between psychosocial or biobehavioral processes on the one hand, and disease on the other. Our studies conducted on HIV-positive (HIV+) homosexual men indicate that a group-based cognitive behavioral stress management (CBSM) intervention can decrease distress, buffer the psychological and immunological sequelae of HIV+ serostatus notification, and improve surveillance of herpes viruses. Decreased dysphoria induced by CBSM appears to be a significant mediator of control over cellular immunity. Poor HIV+ African American women, as well as more affluent gay men, benefit from group-based CBSM, but important gender and sociocultural differences must be taken into account in developing protocols. Adherence to highly active antiretroviral therapy (HAART), coupled with good health behavior, can contain HIV/AIDS in most instances. In contrast, poor HAART adherence coupled with poor health behavior (e.g., unprotected sex) can lead to drug resistance and infection of partners with virulent mutated strains. Thus, now more than ever, behavioral medicine approaches to management and secondary prevention of HIV/AIDS are needed.

Entities:  

Year:  1999        PMID: 16250688     DOI: 10.1207/s15327558ijbm0601_1

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  11 in total

1.  Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers.

Authors:  R M Malow; S M Baker; N Klimas; M H Antoni; N Schneiderman; F J Penedo; D Ziskind; B Page; R McMahon; S McPherson
Journal:  Psychiatr Serv       Date:  1998-08       Impact factor: 3.084

Review 2.  Immune suppression by herpesviruses.

Authors:  C R Rinaldo
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

3.  Patient compliance and drug failure in protease inhibitor monotherapy.

Authors:  G F Vanhove; J M Schapiro; M A Winters; T C Merigan; T F Blaschke
Journal:  JAMA       Date:  1996-12-25       Impact factor: 56.272

4.  Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men.

Authors:  S K Lutgendorf; M H Antoni; G Ironson; K Starr; N Costello; M Zuckerman; N Klimas; M A Fletcher; N Schneiderman
Journal:  Psychosom Med       Date:  1998 Mar-Apr       Impact factor: 4.312

5.  Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-type 2 antibody titers in symptomatic HIV-seropositive gay men.

Authors:  S K Lutgendorf; M H Antoni; G Ironson; N Klimas; M Kumar; K Starr; P McCabe; K Cleven; M A Fletcher; N Schneiderman
Journal:  J Consult Clin Psychol       Date:  1997-02

6.  Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus.

Authors:  G Ironson; A Friedman; N Klimas; M Antoni; M A Fletcher; A Laperriere; J Simoneau; N Schneiderman
Journal:  Int J Behav Med       Date:  1994

7.  Issues in the perception of AIDS risk and risk reduction activities by black and Hispanic/Latina women.

Authors:  V M Mays; S D Cochran
Journal:  Am Psychol       Date:  1988-11

8.  AIDS and the African American woman: the triple burden of race, class, and gender.

Authors:  S C Quinn
Journal:  Health Educ Q       Date:  1993

9.  Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and human herpesvirus type-6 in HIV-1-infected and at-risk gay men.

Authors:  B A Esterling; M H Antoni; N Schneiderman; C S Carver; A LaPerriere; G Ironson; N G Klimas; M A Fletcher
Journal:  Psychosom Med       Date:  1992 May-Jun       Impact factor: 4.312

10.  Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity.

Authors:  M H Antoni; L Baggett; G Ironson; A LaPerriere; S August; N Klimas; N Schneiderman; M A Fletcher
Journal:  J Consult Clin Psychol       Date:  1991-12
View more
  2 in total

1.  Efficacy of a preventive intervention for youths living with HIV.

Authors:  M J Rotheram-Borus; M B Lee; D A Murphy; D Futterman; N Duan; J M Birnbaum; M Lightfoot
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

Review 2.  Untangling the Gordian knot of HIV, stress, and cognitive impairment.

Authors:  Arielle N Valdez; Leah H Rubin; Gretchen N Neigh
Journal:  Neurobiol Stress       Date:  2016-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.